The gold industry has come under close scrutiny from NGOs that are concerned of inhumane conditions at some mines in developing countries.
Keystone / Martin Ruetschi
Campaigning NGO Swissaid faces a lawsuit from gold refinery Valcambi after it refused to retract allegations of suspect dealings with a controversial supplier.
This content was published on
1 minute
swissinfo.ch/mga
Valcambi has already lodged a criminal complaint with prosecutors in canton Bern, according to the Swiss news agency Keystone-SDA. The refinery, based in the southern Swiss canton of Ticino, has now threatened a civil lawsuit.
Earlier this year, Swissaid published a reportExternal link accusing Valcambi of dealing with United Arab Emirates company Kaloti, which it said was a “very controversial player in the industry”. Valcambi has denied that it had been opaque in its business relationships, saying that it had complied with regulations designed to protect gold miners from exploitation.
The refinery threatened to sue Swissaid unless it retracted its report by the end of the month, but the NGO has declined to comply with the demand.
Swissaid stated on its websiteExternal link that it “stands by the research of its study and condemns the threat of a complaint, knowing that the industry shares its concerns. Our demand remains the same: Valcambi must commit itself to human rights in the gold mines.”
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Valcambi refinery denies sourcing ‘dirty’ gold from Dubai
This content was published on
The Swiss-based Valcambi refinery has rejected accusations about gold dealings with a controversial company in the United Arab Emirates.
How do you separate the good companies from the bad apples?
This content was published on
Our analysis of what the biggest global companies in Switzerland are up to. This week: dubious gold origins and vaccine deals.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.